Inotrem bolsters leadership team with the appointment of Sven Zimmermann as new CEO
Paris. March 24, 2021. Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced today the appointment of